The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1053
May 21, 1999
View Complete Issue         Table of Contents 2019 
Issue 1053
Subscribers: Log in to read full issue.  Not a subscriber?  Subscribe or purchase issue.
Generic drugs
May 21, 1999 (Issue: 1053)
When patents expire on brand-name drugs, generic formulations become available that often cost much less. Some physicians, however, hesitate to prescribe the less expensive drug because of concerns about the quality of generic formulations.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this issue?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this issue:
Title: Issue 1053
 


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.